‘It’s Destroyed People’s Lives’: The Shocking Rise in Hepatitis C-Related Deaths
June 22, 2016
Here’s the new way to see a dermatologist: Send a photo of your skin 
June 23, 2016
Show all

What Are the Most Common Cancers in Men?

Consider the screening and prevention strategies for the most common cancers in men.

Information about cancer risk can help you make informed decisions about screening and prevention strategies. As we recognize National Men’s Health Week, learn about the most common cancers in men in the United States and the options for prevention and treatment.

1. Prostate cancer

There will be an estimated 180,890 new cases in the U.S. in 2016.

One in six men will be diagnosed with prostate cancer in his lifetime. Doctors can screen for early signs of prostate cancer with prostate-specific antigen testing, which can detect elevated levels of a protein in the blood that may indicate prostate cancer. There are benefits and drawbacks to PSA testing; it can help detect and treat cancer at an early stage, but it is not always accurate. False readings can lead to unnecessary treatments, including biopsies that can increase the risk of impotence and incontinence.

Dana-Farber experts recommend:

  • Age 18-40: Screening is usually not required.
  • Age 40-49: You should discuss your risk level with your physician. Screening is recommended if you are considered high risk. African-American men and men who have a family history of prostate cancer are at a greater risk and should discuss PSA testing with their physicians.
  • Age 50+: Discuss screening with your physician.

The best protection against prostate cancer is a healthy lifestyle. Follow this game plan for preventing, screening, and treating prostate cancer.

Read Full Article: What Are the Most Common Cancers in Men? – Insight

Read Full Article: What Are the Most Common Cancers in Men? – Insight

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.